Tardive Dyskinesia

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia [Phase 2]

  A Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of NBI-1065890 versus placebo in adults with tardive dyskinesia.

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor [Phase 4]

  Phase 4 trial evaluating valbenazine for tardive dyskinesia in adults who remain symptomatic on or after VMAT2 inhibitor treatment; recruitm…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities [Phase 4]

  This is a Phase 4 clinical trial update for deutetrabenazine targeting tardive dyskinesia in individuals with intellectual or developmental …

• CLINICAL_TRIALS research · 2025-12-05
  Clinical Trial Update: Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD [NA]

  A single-center, double-blind, randomized, placebo-controlled trial is evaluating the efficacy and safety of precise localization rTMS for r…

• CLINICAL_TRIALS research · 2025-05-01
  Clinical Trial Update: ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders [NA]

  Clinical trial update on ExAblate Transcranial MRgFUS for treatment-refractory movement disorders; the study is currently active but not rec…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-01-22
  Clinical Trial Update: Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia [Phase 1, Phase 2]

  This clinical trial update describes ongoing Phase 1/Phase 2 studies evaluating the safety and efficacy of LPM3770164 sustained-release tabl…

• CLINICAL_TRIALS research · 2018-02-26
  Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia. [NA]

  This clinical trial update describes the evaluation of repetitive transcranial magnetic stimulation as a treatment for tardive dyskinesia. T…

• CLINICAL_TRIALS research · 2017-11-22
  Clinical Trial Update: Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

  This clinical trial update describes a real-world screening study and registry to monitor tardive dyskinesia in patients taking antipsychoti…